Prapela, Inc
Prapela is transforming newborn care with FDA-authorized therapy that improves infant health, focusing on innovative stimulation therapy to support infants exposed to opioids and other conditions. Their mission is to help every newborn through breakthrough, evidence-based solutions.
Industries
Nr. of Employees
small (1-50)
Prapela, Inc
Products
Hospital bassinet vibrotactile pad (neonatal adjunctive therapy)
A reusable, disinfectable bassinet pad that delivers low-amplitude stochastic vibrotactile stimulation as an adjunctive non-pharmacological therapy for term newborns with prenatal opioid exposure and withdrawal; designed for bedside hospital use and single on/off operation.
Incubator vibrotactile pad (developmental/pivotal program)
An incubator pad under clinical evaluation designed to reduce apnea and hypoxia in preterm infants and decrease the need for pharmacologic (caffeine) therapy; being tested in NIH‑funded trials.
Hospital bassinet vibrotactile pad (neonatal adjunctive therapy)
A reusable, disinfectable bassinet pad that delivers low-amplitude stochastic vibrotactile stimulation as an adjunctive non-pharmacological therapy for term newborns with prenatal opioid exposure and withdrawal; designed for bedside hospital use and single on/off operation.
Incubator vibrotactile pad (developmental/pivotal program)
An incubator pad under clinical evaluation designed to reduce apnea and hypoxia in preterm infants and decrease the need for pharmacologic (caffeine) therapy; being tested in NIH‑funded trials.
Services
Clinical research collaboration and device evaluation
Partnerships with hospitals and academic centers to conduct randomized and multi-site clinical studies assessing safety and efficacy of neonatal stimulation devices.
Device integration partnerships
Commercial collaboration to integrate vibrotactile stimulation technology into existing neonatal equipment and clinical workflows.
Clinical research collaboration and device evaluation
Partnerships with hospitals and academic centers to conduct randomized and multi-site clinical studies assessing safety and efficacy of neonatal stimulation devices.
Device integration partnerships
Commercial collaboration to integrate vibrotactile stimulation technology into existing neonatal equipment and clinical workflows.
Expertise Areas
- Neonatal clinical trial management
- Non-pharmacological neonatal therapies
- Medical device design for neonates
- Regulatory submissions for novel pediatric devices (FDA De Novo, Breakthrough)
Key Technologies
- Stochastic resonance / vibrotactile stimulation
- Low-voltage vibration actuators
- Biocompatible healthcare surface fabrics
- Clinical randomized controlled trials